Amendment No.1 to Form 8-K

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VX4AY7Nz/AAr76O9qtPW3F652ajKLKWIlCwpX4OHBBxlFNGmnxUTMfKgc7gnNbZu k3FUnJvxz6VAgB8HtDHWgA== 0001193125-07-008414.txt : 20070118 0001193125-07-008414.hdr.sgml : 20070118 20070118160548 ACCESSION NUMBER: 0001193125-07-008414 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070101 ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Changes in Control of Registrant FILED AS OF DATE: 20070118 DATE AS OF CHANGE: 20070118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SONTRA MEDICAL CORP CENTRAL INDEX KEY: 0001031927 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411649949 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-23017 FILM NUMBER: 07537913 BUSINESS ADDRESS: STREET 1: 10 FORGE PARKWAY CITY: FRANKLIN STATE: MA ZIP: 02038 BUSINESS PHONE: 508 553-8850 MAIL ADDRESS: STREET 1: 10 FORGE PARKWAY CITY: FRANKLIN STATE: MA ZIP: 02038 FORMER COMPANY: FORMER CONFORMED NAME: CHOICETEL COMMUNICATIONS INC/MN/ DATE OF NAME CHANGE: 20020701 FORMER COMPANY: FORMER CONFORMED NAME: SONTRA MEDICAL CORP DATE OF NAME CHANGE: 20020701 FORMER COMPANY: FORMER CONFORMED NAME: CHOICETEL COMMUNICATIONS INC /MN/ DATE OF NAME CHANGE: 19970625 8-K/A 1 d8ka.htm AMENDMENT NO.1 TO FORM 8-K Amendment No.1 to Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K/A

AMENDMENT NO. 1 TO

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 1, 2007

SONTRA MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)

Minnesota

000-23017

41-1649949

(State or other jurisdiction

of incorporation)

(Commission

File No.)

(IRS Employer

Identification No.)


10 Forge Parkway, Franklin, Massachusetts		02038
(Address of principal executive offices)		(Zip Code)

(508) 553-8850

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Explanatory Note

Sontra Medical Corporation (the “Company”) is filing this Amendment No. 1 on Form 8-K/A to its Current Report on Form 8-K dated January 1, 2007, as filed with the SEC on January 4, 2007 (the “Original Current Report”) to include certain items that were omitted from the Original Current Report.

The Original Current Report is hereby amended to include the following additional items:

Item 3.02 Unregistered Sales of Equity Securities.

Item 1.01 of the Original Current Report is hereby incorporated herein by reference. No underwriters were involved with the shares of common stock, the warrants to purchase shares of common stock or the shares issuable upon the exercise of the warrants that the Company expects to issue and sell upon the closing of the Financing (as defined in Item 1.01 of the Original Current Report).

Item 5.01 Changes in Control of Registrant.

(b) Item 1.01 of the Original Current Report is hereby incorporated herein by reference. Upon the closing of the Financing (as defined in Item 1.01 of the Original Current Report) the Company expects that the Purchasers (as defined in Item 1.01 of the Original Current Report) will together own approximately 67% of the issued and outstanding shares of common stock of the Company and that, as a result, a change of control of the Company will occur.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Sontra Medical Corporation

Date: January 18, 2007

By: /s/ Harry G. Mitchell

Harry G. Mitchell

Interim Chief Executive Officer

-----END PRIVACY-ENHANCED MESSAGE-----